Trial Details
COMPLETEDBasic Information
| Clinical ID | c1278 |
|---|---|
| Identifier | NCT03482635 |
| Trial Title | BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Spesolimab|DRUG: Placebo |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Hamden |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2018-03-27 |
|---|---|
| Primary Completion Date | 2020-05-18 |
| Completion Date | 2020-05-18 |